Pharma Talk Podcast: Episode #1 Greg Plunkett, CEO of Accelegan

In this edition of Pharm Talk we sit down with Greg Plunkett, CEO of Accelegan, and discuss the major advantages of using an Australian CRO in conjunction with Global CRO Symbio to get Substantial Tax rebates on your upcoming clinical trials.

Back to Resource Center